Accelerated fractionation (AF) compared to conventional fractionation (CF) improves loco-regional control in the radiotherapy of advanced head and neck cancers: Results of the EORTC 22851 randomized trial

Radiotherapy and Oncology

Volumn 44, Issue 2, 1997, Pages 111-121

  Horiot, Jean Claude ^a   Bontemps, Patrick ^b   Van Den Bogaert, Walter ^c   Le Fur, René ^d   Van Den Weijngaert, Danièle ^e   Bolla, Michel ^f   Bernier, Jacques ^g   Lusinchi, Antoine ^h   Stuschke, Martin ⁱ   Lopez Torrecilla, José ^j   Begg, Adrian C ^k   Pierart, Marianne ^l   Collette, Laurence ^l  

^a Tum Inst Ctr Georges Francois L   (France)

^b UNIVERSITY HOSPITAL JEAN MINJOZ   (France)

^c UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^d Ctr Lutte Contre Le Cancer Henri B   (France)

^e MIDDELHEIM HOSPITAL   (Belgium)

^f CHU La Tronche and University   (France)

^g OSPEDALE SAN GIOVANNI   (Switzerland)

^h INSTITUT GUSTAVE ROUSSY   (France)

ⁱ UNIVERSITY HOSPITAL ESSEN   (Germany)

^j INSTITUTO VALENCIANO DE ONCOLOGÍA   (Spain)

^k NETHERLANDS CANCER INSTITUTE   (Netherlands)

^l EORTC DATA CENTER   (Belgium)

more..

Author keywords

Accelerated fractionation; Conventional fracfionation; Head and neck cancers

Indexed keywords

ADULT; ADVANCED CANCER; ARTICLE; CANCER CONTROL; CANCER RADIOTHERAPY; CANCER SURVIVAL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HEAD AND NECK CANCER; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; MYELITIS; PRIORITY JOURNAL; RADIATION DOSE FRACTIONATION; RADIATION INJURY; RANDOMIZED CONTROLLED TRIAL;

ADULT; AGED; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; PATIENT COMPLIANCE; RADIOTHERAPY; SURVIVAL RATE;

EID: 0030842059     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-8140(97)00079-0     Document Type: Article

References (31)

1. Ang, K.K., Trotti, A., Garden, A.S., Foote, R.L., Morrison, W.H., Geara, F.B. and Peters, L.J. Overall time factor in postoperative radiation: results of a prospective randomised trial (abstract 108). Radiother. Oncol. 40 (Suppl. 1): S30, 1996.
2. Barendsen, G.W. Dose fractionation, dose rate and isoeffect relationships for normal tissue response. Int. J. Radiat. Oncol. Biol. Phys. 8: 1981-1997, 1982.
3. Begg, A.C., McNally, N.J., Shrieve, D.C. et al. Method to measure the duration of DNA synthesis and the potential doubling time from a single sample. Cytometry 6: 620-626, 1985.
4. Begg, A.C., Hofland, I., Moonen, L. et al. The predictive value of cell kinetic measurements in a European trial of accelerated fractionation in advanced head and neck tumors: an interim report. Int. J. Radiat. Oncol. Biol. Phys. 19: 1449-1453, 1990.
5. Cox, D.R. Regression models and life-tables. J. R. Statist. Soc. B 34: 187-202, 1972.
6. Cummings, B.J., Keane, T.J., Pintilie, M., O'Sullivan, B., Payne, D., Warde, P., McLean, M., Waldron, J., Liu, F.F., Gullane, P. and the ENT Group. A prospective randomized trial of hyperfractionated versus conventional once daily radiation for advanced squamous cell carcinomas of the pharynx and larynx (abstract 107). Radiother. Oncol. 40 (Suppl. 1): S30, 1996.
7. Dische, S. and Saunders, M.I. Continuous, hyperfractionated, accelerated fractionation (CHART): an interim report upon late morbidity. Radiother. Oncol. 16: 67-74, 1989.
8. Fowler, J.F. and Lindstrom, M.J. Loss of local control with prolongation in radiotherapy. Int. J. Radiat. Oncol. Biol. Phys. 23: 457-467, 1992.
9. Fowler, J.F., Tanner, M.A., Bataini, J.P., Asselain, B., Bernier, J. and Lave, C. Further analysis of the time factor in squamous cell carcinoma of the tonsillar region. Radiother. Oncol. 19: 237-244, 1990.
10. Freedman, L.S. Tables of the number of patients required in clinical trials using the logrank test. Statist. Med. 1: 121-129, 1982.
11. Horiot, J.C., Nabid, A., Chaplain, G. et al. Clinical experience with multiple fractions per day (MFD) in the radiotherapy of head and neck carcinoma. J. Eur. Radiother. 3: 79-89, 1982.
12. Horiot, J.C., Chaplain, G., van der Schueren, E., Gonzalez Gonzalez, D., van den Bogaert, W., van Limbergen, E. and Broadwater, J. A phase III study of accelerated fractionation in the radiotherapy of advanced head and neck carcinoma. EORTC Cooperative Group of Radiotherapy Protocol 22851, EORTC Data Center Brussels, 1985.
13. Horiot, J.C., van den Bogaert, W., Ang, K.K. et al. European Organisation for Research on Treatment of Cancer trials using radiotherapy with multiple fractions per day. A 1978-1987 survey. In: Frontiers of Radiation Therapy and Oncology, pp. 149-161. Editors: J.M. Vaeth and J. Meyer. Karger, Basel, 1988.
14. Horiot, J.C., Le Fur, R., N'Guyen, T. et al. Hyperfractionation versus conventional fractionation in oropharyngeal carcinoma: final analysis of a randomized trial of the EORTC cooperative group of radiotherapy. Radiother. Oncol. 25: 231-241, 1992.
15. Horiot, J.C. and Bernier, J. EORTC 22962. A phase III study comparing conventional versus hyperfractionated radiotherapy, with or without concomitant chemotherapy in head and neck squamous cell carcinoma. EORTC Data Center Brussels, 1996.
16. Kaplan, E.L. and Meier, P. Non parametric estimation from incomplete observations. J. Am. Statist. Assoc. 53: 457-481, 1958.
17. Lindstrom, M.J. and Fowler, J.F. Re-analysis of the time factor in local control by radiotherapy of T3 T4 squamous cell carcinoma of the larynx. Int. J. Radiat. Oncol. Biol. Phys. 21: 813-817, 1991.
18. Maciejewski, B., Preuss-Bayer, G. and Trott, K.R. The influence of the number of fractions and of overall treatment time on local control and late complication rate in squamous cell carcinoma of the larynx. Int. J. Radiat. Oncol. Biol. Phys. 9: 321-328, 1983.
19. Mantel, N. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother. Rep. 50: 163-170, 1966.
20. Overgaard, J., Sand Hansen, H., Sapru, W., Overgaard, M., Grau, C., Jorgensen, K., Bastholt, L., Hansen, O., Specht, L., Berthelsen, A. and Pedersen, M. Conventional radiotherapy as the primary treatment of squamous cell carcinoma (SCC) of the head and neck. A randomised multicenter study of 5 versus 6 fractions per week. Preliminary report from the Dahanca 6 and 7 trial (abstract 110). Radiother. Oncol. 40 (Suppl. 1): S31, 1996.
21. Parsons, J.T., Bova, F.J. and Million, R.R. A re-evaluation of split-course technique for squamous cell carcinoma of the head and neck. Int. J. Radiat. Oncol. Biol. Phys. 6: 1645-1652, 1980.
22. Pavy, J.J., Denekamp, J., Letschert, J., Littbrand, B., Mornex, F., Bernier, J., Gonzalez Gonzalez, D., Horiot, J.C., Bolla, M. and Bartelink, H. Late effects toxicity scoring: the SOMA scale. Radiother. Oncol. 35: 11-15, 1995.
23. Pocock, S.J. and Simon, R. Sequential treatment assignment with balancing for prognostic factors in the controlled clinical trial. Biometrics 31: 103-115, 1975.
24. Saunders, M.I., Dische, S., Barrett, A., Parmar, M.K.B., Harvey, A. and Gibson, D. on behalf of the CHART Steering Committee. Randomised multicentre trials of CHART versus conventional radiotherapy in head and neck and non small cell lung cancer: an interim report. Br. J. Cancer 73: 1455-1462, 1996.
25. Steel, G.G. Tumour growth kinetics. In: Basic Clinical Radiobiology, pp. 8-13. Editor: G.G. Steel. Arnold, London, 1993.
26. van den Bogaert, W., van der Schueren, E., Vantongelen, C., Horiot, J.C., Chaplain, G., Arcangeli, G., Gonzalez, D.G. and Svoboda, V. Late results of multiple fractions per day (MFD) with Misonidazole in advanced cancer of the head and neck. A pilot study of the EORTC radiotherapy group. Radiother. Oncol. 3: 139-144, 1985.
27. van den Bogaert, W., Horiot, J.C. and van der Schueren, E. Radiotherapy with multiple fractions per day. In: The Biological Basis of Radiotherapy, 2nd edn., pp. 209-222. Editors: G.G. Steel, G.E. Adams and A. Horwich. Elsevier, New York, 1989.
28. van den Bogaert, W., van der Schueren, E., Horiot, J.C., de Vilhena, M., Schraub, S., Svoboda, V., Arcangeli, G., de Pauw, M. and van Glabbeke, M. The EORTC randomized trial on three fractions per day and Misonidazole (trial no 22811) in advanced head and neck cancers: long-term results and side effects. Radiother. Oncol. 35:91-99, 1995.
29. van den Bogaert, W., van der Schueren, E., Horiot, J.C., de Vilhena, M., Schraub, S., Svoboda, V., Arcangeli, G., de Pauw, M. and van Glabbeke, M. The EORTC randomized trial on three fractions per day and Misonidazole in advanced head and neck cancers: prognostic factors. Radiother. Oncol. 35: 100-106, 1995.
30. Wang, C.C. Local control of oropharyngeal carcinoma after two accelerated hyperfractionation schemes. Int. J. Radiat. Oncol. Biol. Phys. 14: 1143-1146, 1988.
31. Withers, R. and Horiot, J.C. Hyperfractionation. In: Innovations in Radiation Oncology, pp. 223-230. Editors: R. Withers and L.J. Peters. Springer, Berlin, 1987.